Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Papadopoulos

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cancer|July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanomaOmar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Journal of Translational Medicine|January 30, 2010
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanomaOmar Eton, Merrick I Ross, Mary Jo East, et al.
Angiogenesis|February 4, 2012
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabNicholas Papadopoulos, Joel Martin, Qin Ruan, et al.
Cancer Research|November 15, 2012
Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibitionChristopher Daly, Alexandra Eichten, Carla Castanaro, et al.
Blood|April 19, 2011
The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flowIvan B Lobov, Eunice Cheung, Rajeev Wudali, et al.
Cancer Research|September 18, 2015
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian CancerFrank Kuhnert, Guoying Chen, Sandra Coetzee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockadeJohn S Rudge, Jocelyn Holash, Donna Hylton, et al.
Scientific Reports|January 12, 2018
Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactorChristopher Daly, Xiaozhong Qian, Carla Castanaro, et al.
Bioorganic & Medicinal Chemistry|October 25, 2020
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoidsThomas Nittoli, Frank Delfino, Marcus Kelly, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrated Spatial Analysis of Ovarian Precancerous LesionsTu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cancer|July 13, 2002
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanomaOmar Eton, Michael G Rosenblum, Sewa S Legha, et al.
Journal of Translational Medicine|January 30, 2010
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanomaOmar Eton, Merrick I Ross, Mary Jo East, et al.
Angiogenesis|February 4, 2012
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabNicholas Papadopoulos, Joel Martin, Qin Ruan, et al.
Cancer Research|November 15, 2012
Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibitionChristopher Daly, Alexandra Eichten, Carla Castanaro, et al.
Blood|April 19, 2011
The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flowIvan B Lobov, Eunice Cheung, Rajeev Wudali, et al.
Cancer Research|September 18, 2015
Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian CancerFrank Kuhnert, Guoying Chen, Sandra Coetzee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockadeJohn S Rudge, Jocelyn Holash, Donna Hylton, et al.
Scientific Reports|January 12, 2018
Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactorChristopher Daly, Xiaozhong Qian, Carla Castanaro, et al.
Bioorganic & Medicinal Chemistry|October 25, 2020
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoidsThomas Nittoli, Frank Delfino, Marcus Kelly, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Integrated Spatial Analysis of Ovarian Precancerous LesionsTu-Yung Chang, Yen-Wei Chien, Szu-Hua Chen, et al.
Pageof 4